Ledger.Open graph →
SEC Form D · filed November 20, 2015

EIGER BIOPHARMACEUTICALS INC

Offering
$6.0M
Sold
$6.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
PALO ALTO, CA
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (14)

Jeffrey S. Glenn · Palo Alto, CADirectorThomas J. Dietz · Palo Alto, CADirectorNina S. Kjellson · Palo Alto, CADirectorDavid A. Cory · Palo Alto, CAExec · DirectorEd Engleman · Palo Alto, CADirectorJonathan Weiss · ENCINO, CAExec · DirectorFederico F. Taylor · Dallas, TXDirectorGarry R. Pope · BUFFALO, WYDirectorDan F. Wierck · Austin, TXDirectorJulie Podolec · Dana Point, CADirectorDennis D. Baldwin · Boston, MAExec · DirectorJohn D. Burns · Boston, MADirectorMike S. Sylvestre · Vancouver, British Columbia, CanadaDirectorEd Engleman · Palo Alto, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗